ISSN 1734-1140; 2299-5684;
3 papers in the library · 20 citations · publishing 2023-2026
Pharmacol Rep May 20, 2026 Aleksander Kwaśny, Alina Wilkowska, Michał Pastuszak et al.
Treatment-emergent psychiatric adverse events in patient-reported outcomes during ketamine use for major depressive disorder: a retrospective analysis.
Pharmacol Rep December 1, 2023
Introduction to the thematic collection "Psychedelic Medicine: Therapeutic Applications and Implications for Future Research".
Pharmacol Rep October 30, 2023 Marzena Maćkowiak 20 citations
Abstract Psychedelics are compounds acting by serotonin 5-hydroxytryptamine (5-HT) 2A receptor activation and induce several behavioral responses. They are of special interest because of their positive effects on neuropsychiatric disorders (depression and posttraumatic stress disorder). However, several findings revealed that some psychedelic actions are similar to symptoms observed in...